Evidence map›Paper›PMID 31216065›Full record

Trial reportThe British journal of surgery2019

Randomized clinical trial of accelerated enhanced recovery after minimally invasive colorectal cancer surgery (RecoverMI trial).

B K Bednarski, T P Nickerson, Y N You, C A Messick, B Speer, V Gottumukkala, M Manandhar, M Weldon, E M Dean, W Qiao and 2 more

Registry-linked trialOpen access · greenAbstract readClinical Trial, Phase IIRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The British journal of surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02613728 (Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery), which is not on this map. Cited by 44 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
44citing papers in PubMed, 11 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02613728 nacompletednot on this map

Accelerated Enhanced RECOVERy Following Minimally Invasive Colorectal Cancer Surgery (RecoverMI)

TypeinterventionalSponsorM.D. Anderson Cancer CenterRan2016 to 2022Enrolled32ConditionsColorectal CancerArmsAccelerated Recovery Plan, Early Discharge, Telemedicine, Standard Enhanced Care
3 · Its place in the literature

Who cites it

44 citing papers in PubMed, 11 syntheses or guidelines pooled it, 75 citations in OpenAlex.

  1. Telemedicine interventions after colorectal surgery: A systematic review and meta-analysis.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Enhanced recovery after surgery protocols following emergency intra-abdominal surgery: a systematic review and meta-analysis.European journal of trauma and emergency surgery : official publication of the European Trauma Society · 2024
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Effectiveness of care transition strategies for colorectal cancer patients: a systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  10. Pooled it
  11. The COVID-19 pandemic: considerations for resuming normal colorectal services.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2020
    Guideline
  12. Trial
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

B K BednarskiDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.ORCID 0000-0002-8022-2476
T P NickersonDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Y N YouDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
C A MessickDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
B SpeerDepartment of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
V GottumukkalaDepartment of Anesthesiology and Perioperative Medicine, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
M ManandharDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
M WeldonDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
E M DeanDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
W QiaoDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
X WangDepartment of Biostatistics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
G J ChangDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
The University of Texas MD Anderson Cancer Center · US

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
NCI NIH HHS P30 CA016672
6 · The paper itself

Abstract

backgroundMinimally invasive surgery (MIS) and enhanced recovery protocols (ERPs) have improved postoperative recovery and shortened length of hospital stay (LOS). Telemedicine technology has potential to improve outcomes and patient experience further. This study was designed to determine whether the combination of MIS, ERP and a structured telemedicine programme (TeleRecovery) could shorten total 30-day LOS by 50 per cent.

methodsThis was a phase II prospective RCT at a large academic medical centre. Eligible patients aged 18-80 years undergoing minimally invasive colorectal resection using an ERP were randomized after surgery. The experimental arm (RecoverMI) included accelerated discharge on postoperative day (POD) 1 with or without evidence of bowel function and a televideoconference on POD 2. The control arm was standard postoperative care. The primary endpoint was total 30-day LOS (postoperative stay plus readmission/emergency department/observation days). Secondary endpoints included patient-reported outcomes measured by EQ-5D-5L™, Brief Pain Inventory (BPI) and a satisfaction questionnaire.

resultsThirty patients were randomized after robotic (21 patients) or laparoscopic (9) colectomy, including 14 patients in the RecoverMI arm. Median 30-day total LOS was 28·3 (i.q.r. 23·7-43·6) h in the RecoverMI arm and 51·5 (43·8-67·0) h in the control arm (P = 0·041). There were no differences in severe adverse events or EQ-5D-5L™ score between the study arms. The BPI revealed low pain scores regardless of treatment arm. Satisfaction was high in both arms.

conclusionIn patients having surgery for colorectal neoplasms, the trimodal combination of MIS, ERP and TeleRecovery can reduce 30-day LOS while preserving patients' quality of life and satisfaction. Registration number: NCT02613728 ( https://clinicaltrials.gov).

Indexed as

Enhanced Recovery After SurgeryAdolescentAdultAgedAged, 80 and overColorectal NeoplasmsFemaleHumansLaparoscopyLength of StayMaleMiddle AgedPatient SatisfactionPostoperative PainProspective StudiesQuality of Life

Identifiers

PMID31216065
PMCPMC7938853
OpenAlexW2951074312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.